SCHEMBL6184555

SCHEMBL6184555

COC(=O)c1ccccc1COS(C)(=O)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
LMNA P02545 2/20 0.54
KMT2A Q03164 2/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA5A P35218 1/20 0.49
CA9 Q16790 1/20 0.49
TSHR P16473 2/20 0.48
CFTR P13569 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HTT P42858 1/20 0.46
HIF1A Q16665 1/20 0.46
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
ATM Q13315 1/20 0.45
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPK10 P53779 2/20 0.44
HPGD P15428 1/20 0.44
MAPK8 P45983 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18105807 0.86 ALDH1A1 (0.47) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL18095239 0.86 ALDH1A1 (0.47) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL1982031 0.83 HTT (0.50) ALDH1A1CA1CA2CA9TSHR
SCHEMBL6669086 0.81 ALDH1A1 (0.62) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL3150175 0.81 ALDH1A1 (0.62) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL15461583 0.80 ALDH1A1 (0.57) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL18095230 0.80 ALDH1A1 (0.54) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL3993683 0.79 PTPN1 (0.46) ALDH1A1LMNATSHRHSD17B10KDM4E
SCHEMBL5273095 0.78 CYP1A2 (0.41) ALDH1A1LMNAKMT2ACA1CA2
SCHEMBL7646202 0.78 ALDH1A1 (0.63) ALDH1A1LMNAKMT2ATSHRCFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004050619-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2004-06-17 WO disclosed